Daniel R Passeri - Net Worth and Insider Trading
Daniel R Passeri Net Worth
The estimated net worth of Daniel R Passeri is at least $173,036 dollars as of 2024-11-29. Daniel R Passeri is the CHIEF EXECUTIVE OFFICER of Cue Biopharma Inc and owns about 134,578 shares of Cue Biopharma Inc (CUE) stock worth over $164,185. Daniel R Passeri is also the Director of Curis Inc and owns about 1,989 shares of Curis Inc (CRIS) stock worth over $8,851. Details can be seen in Daniel R Passeri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel R Passeri has not made any transactions after 2023-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel R Passeri
Daniel R Passeri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel R Passeri owns 2 companies in total, including Cue Biopharma Inc (CUE) , and Curis Inc (CRIS) .
Click here to see the complete history of Daniel R Passeri’s form 4 insider trades.
Insider Ownership Summary of Daniel R Passeri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2023-08-14 | director & CEO |
| CRIS | Curis Inc | 2015-12-30 | Chief Executive Officer |
Daniel R Passeri Latest Holdings Summary
Daniel R Passeri currently owns a total of 2 stocks. Among these stocks, Daniel R Passeri owns 134,578 shares of Cue Biopharma Inc (CUE) as of August 14, 2023, with a value of $164,185 and a weighting of 94.88%. Daniel R Passeri also owns 1,989 shares of Curis Inc (CRIS) as of December 30, 2015, with a value of $8,851 and a weighting of 5.12%.
Latest Holdings of Daniel R Passeri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2023-08-14 | 134,578 | 1.22 | 164,185 |
| CRIS | Curis Inc | 2015-12-30 | 1,989 | 4.45 | 8,851 |
Holding Weightings of Daniel R Passeri
Daniel R Passeri Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel R Passeri has made a total of 2 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cue Biopharma Inc is the acquisition of 3,000 shares on August 14, 2023, which cost Daniel R Passeri around $8,580.
According to the SEC Form 4 filings, Daniel R Passeri has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the sale of 256 shares on December 30, 2015, which brought Daniel R Passeri around $76,032.
Insider Trading History of Daniel R Passeri
- 1
Daniel R Passeri Trading Performance
GuruFocus tracks the stock performance after each of Daniel R Passeri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel R Passeri is -11.6%. GuruFocus also compares Daniel R Passeri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel R Passeri within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel R Passeri's insider trading performs compared to the benchmark.
Performance of Daniel R Passeri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.33 | | | | | |
| Relative Return to S&P 500(%) | -2.36 | | | | | |
Daniel R Passeri Ownership Network
Daniel R Passeri Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Daniel R Passeri is the director & CEO of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , Chief Medical Officer Matteo Levisetti , and Chief Business Officer Patricia Nasshorn .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Daniel R Passeri made 1 insider transaction in Cue Biopharma Inc (CUE) with a net purchase of 3,000. Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 4,000 shares made by Anish Suri ,
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Daniel R Passeri Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel R Passeri. You might contact Daniel R Passeri via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
